TF-IUPS160037 252..255 REVIEW ARTICLE Prevention of unintended pregnancy and use of contraception—important factors for preconception care Helena Kopp Kallnera,b and Kristina Gemzell Danielssona aDepartment of Women’s and Children’s Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden; bDepartment of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden ABSTRACT Preservation of fertility and optimizing health before pregnancy is becoming increasingly important in societies where childbirth often is postponed. Research shows that as women postpone childbirth they achieve higher levels of education and higher incomes. This leads to advantages for their children and for society. However, as women postpone childbearing they are at risk for contracting conditions which may affect fertility and/or pregnancies, pregnancy outcome, and the newborn child. Preconception counseling is therefore becoming increasingly important. Women are often unaware of the added health benefits of contraception and have the right to be well informed so they can make decisions to fulfill their reproductive desires. Contraception can reduce the risk of unintended pregnancies, ectopic and molar pregnancies, and sexually transmitted infections. In addition, hormonal contraceptives reduce the risk of some types of cancer, dysmenorrhea, heavy menstrual bleeding, and anemia and are a treat- ment for endometriosis. Contraception should increasingly be looked upon as a means of preserving fertility and optimizing health status before a planned pregnancy. Thus, effective contraception can pro- vide women with a possibility of achieving their long-term reproductive goals, although childbearing is actually postponed. The most effective contraceptive methods are the long-acting reversible contracep- tives, which have been shown to be highly effective especially in young women who have difficulties with adherence to user-dependent methods. Therefore, these methods should increasingly be promoted in all age groups. ARTICLE HISTORY Received 10 March 2016 Revised 24 June 2016 Accepted 28 June 2016 KEYWORDS Added health benefits; combined hormonal contraception; contraception; long-acting reversible contraception; preconception care; unintended pregnancy Introduction Preservation of fertility and optimizing health before preg- nancy is becoming increasingly important in societies where childbirth often is postponed. The average age of first child- birth has steadily been rising in the OECD countries, with first-time mothers’ mean age being 28.2 years in 2014 (1). In the United States the mean age of first-time mothers is 26.3 years (2). Postponing childbirth has advantages for women and society. Research shows that as women postpone child- birth they achieve higher levels of education and higher incomes (3,4). This leads to advantages for their children and for society (5,6). As women postpone childbirth and have fewer children, they are in need of contraceptives for longer periods. These contraceptives must also be highly effective as women are postponing childbirth during the period in life with the high- est fertility. Risks of unintended pregnancies do not only include risk of abortion and abortion-related complications but also risk of ectopic pregnancy, which may reduce future fertility, and risk of molar pregnancy that may lead to malig- nancy. Postponing childbirth may also subject women to greater risks of contracting intercurrent conditions such as sexually transmitted infections (STIs) and endometriosis, which can affect fertility. Other conditions such as heavy menstrual bleeding may lead to anemia and affect women’s health before, during, and after pregnancy. Contraception can reduce the risk of unintended pregnancies, ectopic and molar pregnancies, and STIs. In addition, hormonal contraceptives reduce the risk of some types of cancer, dysmenorrhea, and heavy menstrual bleeding and are a treatment for endometri- osis. Women are generally unaware of the added health ben- efits of contraception. In a Swedish study 57% of women could not mention any added health benefits of contracep- tion (7). Information and knowledge about the fertility- preserving capacity of contraceptives and their added health benefits needs to be increased in society. Prevention of unintended pregnancy Worldwide approximately 40% of pregnancies are unin- tended, although rates vary across countries and regions (8). Unintended pregnancy may result in several outcomes such as birth, miscarriage, induced abortion, ectopic pregnancy, and molar pregnancy. The prevention of unintended preg- nancies through the availability of effective contraceptives has changed lives for women, children, and society. CONTACT Helena Kopp Kallner, MD, PhD Helena.kopp-kallner@ki.se Department of Women’s and Children’s Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Danderyd Hospital, 182 88 Stockholm, Sweden. � 2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. UPSALA JOURNAL OF MEDICAL SCIENCES, 2016 VOL. 121, NO. 4, 252–255 http://dx.doi.org/10.1080/03009734.2016.1208310 http://creativecommons.org/licenses/by/4.0/ Prevention of adolescent pregnancy Teenage mothers have higher risks of pre-term birth, pre- natal and post-partum depression, substance and alcohol abuse, and harsher parenting style (9). In addition, offspring to teenage mothers had worse results in school, higher levels of psychopathology, higher levels of criminal activity, and greater substance abuse levels (9). Prevention of adolescent pregnancies should therefore be a high priority in society. In the United States 86% of the decline in teenage pregnancy rates over the last 40 years has been attributed to contracep- tion (10). Several studies have examined adherence to differ- ent contraceptives among adolescents. Young women have more problems with adherence to methods that require daily, weekly, or monthly administration. Long-acting reversible methods have been shown to prevent adolescent pregnan- cies to a larger extent than user-dependent methods (11,12). Long-acting methods have also been shown to have lower discontinuation rates (13). In spite of these findings the contraceptive pill is still the most prescribed method among young women in the United States (14) and in Europe (15). Due to their superior effectiveness in preventing unintended pregnancies, long-acting reversible contraceptives should be promoted among adolescents. Prevention of ectopic pregnancy and molar pregnancy Worldwide approximately 1%–2% of all pregnancies are ectopic. Ectopic pregnancy has a negative effect of future fer- tility according to several studies (16–19) and is costly for society, with hospital visits, admissions, and absence from work, but also personally for women, with reduced fertility rates. Ectopic pregnancy often affects young women who most likely desire preserved fertility (16). Ectopic pregnancy due to a planned pregnancy may be considered as inevitable, but ectopic pregnancies may also be due to an unintended pregnancy. In this group of women it is especially important to prevent repeat ectopic pregnancy through adequate contraceptive counseling. All contraceptives protect against conception and therefore decrease the risk of ectopic preg- nancy (20,21). With adequate contraceptive counseling, not only abortions would be avoided but also the suffering and costs from an ectopic pregnancy. Risk factors for ectopic pregnancy such as pelvic inflamma- tory disease (PID), usually caused by Chlamydia trachomatis or Gonorrhea, and endometriosis may also be reduced by contraceptive use. However, the greatest risk factor for ectopic pregnancy is previous ectopic pregnancy, with a recurrent rate of 10%–15% (16,22). Ectopic pregnancies can be life-threatening due to intra-abdominal bleeding caused by tubal rupture, tubal abortion, or operative/postoperative complications. It is the most common reason for maternal mortality during the first trimester and is responsible for 9% of pregnancy-related deaths in the US (23). The most effective method for prevention of ectopic preg- nancy is the contraceptive implant which prevents ovulation and is a long-acting reversible method. It is unknown what proportion of women receive information on the relative ability of different contraceptives to prevent repeat ectopic pregnancy. Molar pregnancy or trophoblastic disease is a rare condi- tion present in 0.57–2 per 1,000 pregnancies (24). Molar preg- nancy needs to be surgically evacuated and entails a larger risk of hemorrhage compared to surgical evacuation of nor- mal pregnancy. Although the condition has a cure rate of approximately 98% in developed countries, it imposes restric- tions on women during the follow-up period and may involve aggressive treatment (25). Methods for prevention of unintended pregnancy In order to prevent unintended pregnancy, the ‘typical use’ effectiveness rather than the ‘perfect use’ effectiveness of contraceptive methods should be considered in contraceptive counseling. It has been shown that structured counseling and the cost of contraception can influence the contraceptive method that women decide to use (12,26). Conventional sour- ces of information on contraceptives such as information from pharmaceutical companies do not contain information on typical use effectiveness, and this may therefore not be common knowledge among providers, nor among women. Recently, the importance of long-acting reversible contracep- tive methods (LARC; implants and intrauterine contraception) in reducing the rate of unwanted pregnancy, abortion, and repeat abortion has been shown (12,27,28). New methods for increasing the effectiveness of short-acting methods such as the pill, patch, and ring have also been explored. A shorter hormone-free interval has been shown to increase the effect- iveness of the typical use of the combined hormonal contra- ceptive pill. In addition, combined hormonal contraceptive pills containing a progestin with a longer half-life have also been shown to increase effectiveness (29). It has been specu- lated that continuous use of combined hormonal contracep- tives may be the most effective way of using these methods. However, no such prospective studies powered for detection of a difference in rates of unintended pregnancies have been published. Added health benefits of hormonal contraception The first contraceptive pill was not approved on the indica- tion contraception (which was illegal at that time) but for treatment of menstrual symptoms such as dysmenorrhea and heavy menstrual bleeding. In addition, combined hormonal contraceptives have been shown to reduce the risk of several cancers such as ovarian cancer, endometrial cancer, and colon cancer as shown in several large prospective cohort studies (30–32). Use of the intrauterine system containing 52 mg levo- norgestrel (release rate 20 lg levonorgestrel per 24 hours), has been shown to reverse precancerous conditions in the endo- metrium (33). Making women aware of the health benefits of hormonal contraception could increase the use of effective contraceptives among women and optimize preconception health status. As women postpone childbirth and subse- quently become older when they have their first child, more women are exposed to the risk of cancer, which increases UPSALA JOURNAL OF MEDICAL SCIENCES 253 with age. The risk of cancer and impairment of fertility may be reduced by contraceptive use. Treatment of dysmenorrhea and endometriosis Among women and adolescents with severe dysmenorrhea it is estimated that 25%–75% have endometriosis (34,35). The main treatment of endometriosis is progestins, and the first- line recommended treatment is combined hormonal contra- ception (36). Endometriosis is present in 25%–40% of infertile women (37). The aim of the medical treatment with progestins is to achieve anovulation and amenorrhea whereby the inflammatory response, endometriomas, and adhesions are prevented (38). These may otherwise cause infertility from the need of ovarian surgery with reduction in the ovarian reserve and lesions causing tubal infertility. Treatment for dysmenorrhea in adolescents should take into account that it may be caused by endometriosis and that endometriosis in adolescents may be aggressive. Treatment with progestins can prevent disease progression and future infertility (39). However, contraceptive pills cannot treat infer- tility caused by endometriosis (40). Heavy menstrual bleeding Heavy menstrual bleeding is present in 4%–22% of women, depending on which method is used for evaluation of men- strual bleeding, and iron deficiency anemia is present in 5%–10% of women of fertile age (41). The main cause of iron deficiency anemia in fertile women is heavy menstrual bleed- ing (41). Heavy menstrual bleeding increases with age (42). Thus, as women postpone childbirth, they become more exposed to the risk of heavy menstrual bleeding and subse- quent anemia. Women with normal hemoglobin levels may still have iron deficiency. Thus, they have depleted the iron depots, most likely due to heavy menstrual bleeding, but are maintaining normal hemoglobin values. Recent research shows that women with iron depletion but normal hemoglo- bin levels may have less resistance to muscular fatigue. Suggested neuropsychological effects are, among others, depression and impaired learning and memory abilities (43). The increased need of iron during pregnancy induces iron deficiency anemia in women with reduced iron depots, and iron supplementation is necessary. It has been shown that approximately 10.5% of women in the Helsinki area in Finland have iron deficiency anemia when they present for delivery (44). Iron deficiency anemia puts the mother at higher risk during childbirth, and she also has a higher risk of post-partum infections. Anemia may also impact on the ability to breastfeed (45,46). In the Finnish register study (44) anemia at presentation for delivery was associated with a higher risk for pre-term delivery, cesarean section, and neonatal intensive care admission of the newborn. Post-partum anemia is also linked to post-partum depression, reduced quality of life, and reduced cognitive abilities (46). Thus, it is essential for women to enter pregnancy with an optimal iron status in order to maintain health during and after pregnancy. Prevention of anemia during pregnancy must be taken seriously, and precautions should be taken early in pregnancy to reduce the risk for adverse pregnancy, delivery, and post-delivery out- comes. When anemia is discovered in early pregnancy a detailed menstrual bleeding history should be taken, and women should be informed about contraceptives which reduce menstrual blood loss in order to optimize future health. Conclusion As women postpone childbirth they have an increased need for pre-conception contraceptive counseling. The counseling should focus on the long-term need for effective contracep- tion and avoidance of the consequences of unintended preg- nancy such as ectopic pregnancy which reduces future fertility. In addition, pre-conception added health benefits should be stressed. These include prevention of the conse- quences of heavy menstrual bleeding, anemia, and untreated endometriosis but also of several cancers. During contracep- tive counseling the effectiveness of any method in typical use and the superior effectiveness of long-acting methods should be stressed. Declaration of interest H.K.K. and K.G.D. have both served on advisory boards for MSD, Bayer, and Gedeon Richter. H.K.K. and K.G.D. have both received honorariums for giving lectures for MSD, Bayer, Gedeon Richter, and Actavis on the topic of contraception and abortion. H.K.K. and K.G.D. have both participated in stud- ies on contraception sponsored by MSD and Gedeon Richter, and, in the case of K.G.D., also Bayer. ORCID Helena Kopp Kallner http://orcid.org/0000-0001-7184-9165 References 1. 2015. Available from: www.oecd.org/els/family/database.htm. 2. Mathews TJ, Hamilton BE. Mean age of mothers is on the rise: United States, 2000–2014. NCHS Data Brief. 2016(232):1–8. 3. Bailey MJ, Hershbein B, Miller AR. The opt-in revolution? Contraception and the gender gap in wages. Am Econ J Appl Econ. 2012;4:225–54. 4. Hock H. The pill and the college atainment of American women and men. Working paper. Florida State University; 2007. 5. Bailey MJ, Malkova O, Norling J. Do family planning programs decrease poverty? Evidence from public census data. CESifo Econ Stud. 2014;60:312–37. 6. Bailey MJ. Fifty years of family planning: new evidence on the long-run effects of increasing access to contraception. Brookings Pap Econ Act. 2013;2013:341–409. 7. Kopp Kallner H, Thunell L, Brynhildsen J, Lindeberg M, Gemzell Danielsson K. Use of contraception and attitudes towards contra- ceptive use in Swedish women–a nationwide survey. PLoS One. 2015;10:e0125990. 8. Sedgh G, Singh S, Hussain R. Intended and unintended pregnancies worldwide in 2012 and recent trends. Stud Fam Plann. 2014;45:301–14. 254 H. KOPP KALLNER AND K. GEMZELL DANIELSSON http://www.oecd.org/els/family/database.htm 9. Siegel RS, Brandon AR. Adolescents, pregnancy, and mental health. J Pediatr Adolesc Gynecol. 2014;27:138–50. 10. Santelli JS, Lindberg LD, Finer LB, Singh S. Explaining recent declines in adolescent pregnancy in the United States: the contri- bution of abstinence and improved contraceptive use. Am J Public Health. 2007;97:150–6. 11. Bharadwaj P, Akintomide H, Brima N, Copas A, D’Souza R. Determinants of long-acting reversible contraceptive (LARC) use by adolescent girls and young women. Eur J Contracept Reprod Health Care. 2012;17:298–306. 12. Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998–2007. 13. Reeves MF, Zhao Q, Secura GM, Peipert JF. Risk of unintended pregnancy based on intended compared to actual contraceptive use. Am J Obstet Gynecol. 2016;215:71.e1–6 . 14. Martinez G, Copen CE, Abma JC. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006–2010 national survey of family growth. Vital Health Stat 23. 2011:1–35. 15. Avery L, Lazdane G. What do we know about sexual and reproduct- ive health of adolescents in Europe? Eur J Contracept Reprod Health Care. 2010;15(Suppl 2):S54–S66. 16. Juneau C, Bates GW. Reproductive outcomes after medical and sur- gical management of ectopic pregnancy. Clin Obstet Gynecol. 2012;55:455–60. 17. Egerup P, Karhus LL, Skovlund CW, Lidegaard O. Improving repro- ductive long-term prognosis for women with a first ectopic preg- nancy. A national controlled follow-up study. Acta Obstet Gynecol Scand. 2014;93:490–6. 18. de Bennetot M, Rabischong B, Aublet-Cuvelier B, Belard F, Fernandez H, Bouyer J, et al. Fertility after tubal ectopic pregnancy: results of a population-based study. Fertil Steril. 2012;98:1271–6 e1–3. 19. Bhattacharya S, McLernon DJ, Lee AJ. Reproductive outcomes fol- lowing ectopic pregnancy: register-based retrospective cohort study. PLoS Med. 2012;9:e1001243. 20. Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol. 2004;190(4 Suppl):S5–S22. 21. Walker JJ. Ectopic pregnancy. Clin Obstet Gynecol. 2007;50:89–99. 22. Marion LL, Meeks GR. Ectopic pregnancy: history, incidence, epi- demiology, and risk factors. Clin Obstet Gynecol. 2012;55:376–86. 23. Barash JH, Buchanan EM, Hillson C. Diagnosis and management of ectopic pregnancy. Am Fam Physician. 2014;90:34–40. 24. Atrash HK, Hogue CJ, Grimes DA. Epidemiology of hydatidiform mole during early gestation. Am J Obstet Gynecol. 1986;154:906–9. 25. Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet. 2010;376:717–29. 26. Bitzer J, Gemzell-Danielsson K, Roumen F, Marintcheva-Petrova M, van Bakel B, Oddens BJ. The CHOICE study: effect of counselling on the selection of combined hormonal contraceptive methods in 11 countries. Eur J Contracept Reprod Health Care. 2012;17:65–78. 27. Rose SB, Lawton BA. Impact of long-acting reversible contraception on return for repeat abortion. Am J Obstet Gynecol. 2012;206:37 e1–6. 28. Cameron ST, Glasier A, Chen ZE, Johnstone A, Dunlop C, Heller R. Effect of contraception provided at termination of pregnancy and incidence of subsequent termination of pregnancy. BJOG. 2012;119:1074–80. 29. Dinger J, Minh TD, Buttmann N, Bardenheuer K. Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progesto- gen and regimen. Obstet Gynecol. 2011;117:33–40. 30. Vessey MP, Lawless M. The Oxford-Family Planning Association contraceptive study. Clin Obstet Gynaecol. 1984;11:743–57. 31. Vessey M, Yeates D, Flynn S. Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. Contraception. 2010;82:221–9. 32. Hannaford PC, Iversen L, Macfarlane TV, Elliott AM, Angus V, Lee AJ. Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners’ Oral Contraception Study. BMJ. 2010;340:c927. 33. Baker J, Obermair A, Gebski V, Janda M. Efficacy of oral or intrauter- ine device-delivered progestin in patients with complex endomet- rial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature. Gynecol Oncol. 2012;125:263–70. 34. Black AY, Jamieson MA. Adolescent endometriosis. Curr Opin Obstet Gynecol. 2002;14:467–74. 35. Propst AM, Laufer MR. Endometriosis in adolescents. Incidence, diagnosis and treatment. J Reprod Med. 1999;44:751–8. 36. Templeman C. Adolescent endometriosis. Curr Opin Obstet Gynecol. 2012;24:288–92. 37. Child TJ, Tan SL. Endometriosis: aetiology, pathogenesis and treat- ment. Drugs. 2001;61:1735–50. 38. Barnhart K, Mirkin S, Grubb G, Constantine G. Return to fertility after cessation of a continuous oral contraceptive. Fertil Steril. 2009;91:1654–6. 39. Brosens I, Gordts S, Benagiano G. Endometriosis in adolescents is a hidden, progressive and severe disease that deserves attention, not just compassion. Hum Reprod. 2013;28:2026–31. 40. Hughes E, Brown J, Collins JJ, Farquhar C, Fedorkow DM, Vandekerckhove P. Ovulation suppression for endometriosis. Cochrane Database Syst Rev. 2007:CD000155. 41. National Collaborating Centre for Women’s and Children’s Health (UK). Heavy menstrual bleeding. National Institute for Health and Clinical Excellence: Guidance. London: RCOG Press; 2007. 42. Hale GE, Manconi F, Luscombe G, Fraser IS. Quantitative measure- ments of menstrual blood loss in ovulatory and anovulatory cycles in middle- and late-reproductive age and the menopausal transi- tion. Obstet Gynecol. 2010;115(2 Pt 1):249–56. 43. Coad J, Conlon C. Iron deficiency in women: assessment, causes and consequences. Curr Opin Clin Nutr Metab Care. 2011;14:625–34. 44. Drukker L, Hants Y, Farkash R, Ruchlemer R, Samueloff A, Grisaru- Granovsky S. Iron deficiency anemia at admission for labor and delivery is associated with an increased risk for Cesarean section and adverse maternal and neonatal outcomes. Transfusion. 2015;55:2799–806. 45. Bergmann RL, Richter R, Bergmann KE, Dudenhausen JW. Prevalence and risk factors for early postpartum anemia. Eur J Obstet Gynecol Reprod Biol. 2010;150:126–31. 46. Milman N. Postpartum anemia I: definition, prevalence, causes, and consequences. Ann Hematol. 2011;90:1247–53. UPSALA JOURNAL OF MEDICAL SCIENCES 255 Prevention of unintended pregnancy and use of contraception—important factors for preconception care Introduction Prevention of unintended pregnancy Prevention of adolescent pregnancy Prevention of ectopic pregnancy and molar pregnancy Methods for prevention of unintended pregnancy Added health benefits of hormonal contraception Treatment of dysmenorrhea and endometriosis Heavy menstrual bleeding Conclusion Declaration of interest References